111 related articles for article (PubMed ID: 25783947)
1. Natriuretic peptides for risk stratification of patients with valvular aortic stenosis.
Parikh V; Kim C; Siegel RJ; Arsanjani R; Rader F
Circ Heart Fail; 2015 Mar; 8(2):373-80. PubMed ID: 25783947
[No Abstract] [Full Text] [Related]
2. Nt-ProBNP Discriminatory Role Between Symptomatic and Asymptomatic Patients with Severe Valvular Aortic Stenosis.
Antova E; Petkovska L; Bosevski M; Stojkovik J; Hadzy-Petrushev N; Kamkin A; Mladenov M
Pril (Makedon Akad Nauk Umet Odd Med Nauki); 2018 Jul; 39(1):15-28. PubMed ID: 30110268
[No Abstract] [Full Text] [Related]
3. Heartbeat: Risk stratification for asymptomatic severe aortic stenosis.
Otto CM
Heart; 2019 Mar; 105(5):347-349. PubMed ID: 31693480
[No Abstract] [Full Text] [Related]
4. Natriuretic peptides in patients with aortic stenosis.
Qi W; Mathisen P; Kjekshus J; Simonsen S; Bjørnerheim R; Endresen K; Hall C
Am Heart J; 2001 Oct; 142(4):725-32. PubMed ID: 11579366
[TBL] [Abstract][Full Text] [Related]
5. NT-proBNP changes, oxidative stress, and energy status of hypertrophic myocardium following ischemia/reperfusion injury.
Scolletta S; Carlucci F; Biagioli B; Marchetti L; Maccherini M; Carlucci G; Rosi F; Salvi M; Tabucchi A
Biomed Pharmacother; 2007; 61(2-3):160-6. PubMed ID: 17350221
[TBL] [Abstract][Full Text] [Related]
6. NT-proBNP for risk stratification of nonagenarian patients with severe symptomatic aortic stenosis.
Raposeiras-Roubín S; Abu-Assi E; López-Rodríguez E; Agra-Bermejo R; Pereira-López EM; Calvo-Iglesias F; Íñiguez-Romo A
Int J Cardiol; 2016 Nov; 223():785-786. PubMed ID: 27573609
[No Abstract] [Full Text] [Related]
7. The effect of aortic valve replacement on plasma B-type natriuretic peptide in patients with severe aortic stenosis--one year follow-up.
Neverdal NO; Knudsen CW; Husebye T; Vengen OA; Pepper J; Lie M; Tønnessen T
Eur J Heart Fail; 2006 May; 8(3):257-62. PubMed ID: 16466963
[TBL] [Abstract][Full Text] [Related]
8. Prognostic value of NT-proBNP and an adapted monin score in patients with asymptomatic aortic stenosis.
Farré N; Gómez M; Molina L; Cladellas M; Blé M; Roqueta C; Ascoeta MS; Comin-Colet J; Vila J; Bruguera J
Rev Esp Cardiol (Engl Ed); 2014 Jan; 67(1):52-7. PubMed ID: 24774264
[TBL] [Abstract][Full Text] [Related]
9. [Biomarkers for the evaluation of valvular aortic stenosis].
Weber M; Hamm C
Herz; 2006 Oct; 31(7):658-63. PubMed ID: 17072779
[TBL] [Abstract][Full Text] [Related]
10. Predictors of outcome in patients with severe aortic stenosis and normal left ventricular function: role of B-type natriuretic peptide.
Lim P; Monin JL; Monchi M; Garot J; Pasquet A; Hittinger L; Vanoverschelde JL; Carayon A; Gueret P
Eur Heart J; 2004 Nov; 25(22):2048-53. PubMed ID: 15541842
[TBL] [Abstract][Full Text] [Related]
11. Plasma levels of brain natriuretic peptide in various forms of obstruction to the left ventricular outflow tract.
Fukuda N; Shinohara H; Sakabe K; Nada T; Tamura Y
J Heart Valve Dis; 2003 May; 12(3):333-40. PubMed ID: 12803333
[TBL] [Abstract][Full Text] [Related]
12. Brain natriuretic peptide release in patients with aortic stenosis: resting and exercise echocardiographic determinants.
Henri C; Magne J; Dulgheru R; Laaraibi S; Voilliot D; Kou S; Pierard L; Lancellotti P
Int J Cardiol; 2014 Apr; 172(3):611-3. PubMed ID: 24502879
[No Abstract] [Full Text] [Related]
13. Pro B-type natriuretic peptide plasma value: a new criterion for the prediction of short- and long-term outcomes after transcatheter aortic valve implantation.
López-Otero D; Trillo-Nouche R; Gude F; Cid-Álvarez B; Ocaranza-Sanchez R; Alvarez MS; Lear PV; Gonzalez-Juanatey JR
Int J Cardiol; 2013 Sep; 168(2):1264-8. PubMed ID: 23280329
[TBL] [Abstract][Full Text] [Related]
14. Usefulness of plasma B-type natriuretic peptide in the assessment of disease severity and prediction of outcome after aortic valve replacement in patients with severe aortic stenosis.
Iwahashi N; Nakatani S; Umemura S; Kimura K; Kitakaze M
J Am Soc Echocardiogr; 2011 Sep; 24(9):984-91. PubMed ID: 21570253
[TBL] [Abstract][Full Text] [Related]
15. The evolution and prognostic value of N-terminal brain natriuretic peptide in predicting 1-year mortality in patients following transcatheter aortic valve implantation.
Elhmidi Y; Bleiziffer S; Piazza N; Ruge H; Krane M; Deutsch MA; Hettich I; Voss B; Mazzitelli D; Lange R
J Invasive Cardiol; 2013 Jan; 25(1):38-44. PubMed ID: 23293174
[TBL] [Abstract][Full Text] [Related]
16. Relation of N-terminal pro-B-type natriuretic peptide to severity of valvular aortic stenosis.
Weber M; Arnold R; Rau M; Brandt R; Berkovitsch A; Mitrovic V; Hamm C
Am J Cardiol; 2004 Sep; 94(6):740-5. PubMed ID: 15374777
[TBL] [Abstract][Full Text] [Related]
17. Left ventricular hypertrophy in valvular aortic stenosis: mechanisms and clinical implications.
Rader F; Sachdev E; Arsanjani R; Siegel RJ
Am J Med; 2015 Apr; 128(4):344-52. PubMed ID: 25460869
[TBL] [Abstract][Full Text] [Related]
18. Transcardiac gradients of circulating apelin: extraction by normal hearts vs. release by hearts failing due to pressure overload.
Helske S; Kovanen PT; Lommi J; Turto H; Kupari M
J Appl Physiol (1985); 2010 Dec; 109(6):1744-8. PubMed ID: 20864562
[TBL] [Abstract][Full Text] [Related]
19. Influence of atypical symptoms and electrocardiographic signs of left ventricular hypertrophy or ST-segment/T-wave abnormalities on the natural history of otherwise asymptomatic adults with moderate to severe aortic stenosis: preliminary communication.
Hering D; Piper C; Horstkotte D
J Heart Valve Dis; 2004 Mar; 13(2):182-7. PubMed ID: 15086255
[TBL] [Abstract][Full Text] [Related]
20. The role of biomarkers in valvular heart disease: focus on natriuretic peptides.
Bergler-Klein J; Gyöngyösi M; Maurer G
Can J Cardiol; 2014 Sep; 30(9):1027-34. PubMed ID: 25151285
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
